PROFUSA INC (PFSA) Fundamental Analysis & Valuation

NASDAQ:PFSA • US74319X2071

Current stock price

0.692 USD
+0.05 (+6.99%)
At close:
0.687 USD
0 (-0.72%)
After Hours:

This PFSA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PFSA Profitability Analysis

1.1 Basic Checks

  • PFSA had negative earnings in the past year.
  • PFSA had a negative operating cash flow in the past year.
PFSA Yearly Net Income VS EBIT VS OCF VS FCFPFSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

  • PFSA has a Return On Assets of -919.85%. This is amonst the worse of the industry: PFSA underperforms 96.81% of its industry peers.
Industry RankSector Rank
ROA -919.85%
ROE N/A
ROIC N/A
ROA(3y)-29.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PFSA Yearly ROA, ROE, ROICPFSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PFSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PFSA Yearly Profit, Operating, Gross MarginsPFSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. PFSA Health Analysis

2.1 Basic Checks

  • PFSA has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for PFSA is higher compared to a year ago.
PFSA Yearly Shares OutstandingPFSA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 100K 200K 300K
PFSA Yearly Total Debt VS Total AssetsPFSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -73.89, we must say that PFSA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of PFSA (-73.89) is worse than 96.28% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -73.89
ROIC/WACCN/A
WACCN/A
PFSA Yearly LT Debt VS Equity VS FCFPFSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.18 indicates that PFSA may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.18, PFSA is doing worse than 94.15% of the companies in the same industry.
  • PFSA has a Quick Ratio of 0.18. This is a bad value and indicates that PFSA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PFSA's Quick ratio of 0.18 is on the low side compared to the rest of the industry. PFSA is outperformed by 93.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
PFSA Yearly Current Assets VS Current LiabilitesPFSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. PFSA Growth Analysis

3.1 Past

  • The earnings per share for PFSA have decreased strongly by -2240.33% in the last year.
EPS 1Y (TTM)-2240.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4662.3%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. PFSA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PFSA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PFSA Price Earnings VS Forward Price EarningsPFSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PFSA Per share dataPFSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -50 -100 -150 -200 -250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PFSA Dividend Analysis

5.1 Amount

  • No dividends for PFSA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PFSA Fundamentals: All Metrics, Ratios and Statistics

PROFUSA INC

NASDAQ:PFSA (4/17/2026, 8:00:00 PM)

After market: 0.687 0 (-0.72%)

0.692

+0.05 (+6.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-06
Earnings (Next)06-02
Inst Owners4.62%
Inst Owner Change329.88%
Ins Owners4.69%
Ins Owner Change-162.67%
Market Cap941.12K
Revenue(TTM)N/A
Net Income(TTM)-39.09M
AnalystsN/A
Price TargetN/A
Short Float %3.52%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-278.73
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-8.42
FCFYN/A
OCF(TTM)-8.42
OCFYN/A
SpS0
BVpS-24.97
TBVpS-24.97
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -919.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z -73.89
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2240.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4662.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1469.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-502.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-502.54%
OCF growth 3YN/A
OCF growth 5YN/A

PROFUSA INC / PFSA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PROFUSA INC?

ChartMill assigns a fundamental rating of 0 / 10 to PFSA.


What is the valuation status for PFSA stock?

ChartMill assigns a valuation rating of 0 / 10 to PROFUSA INC (PFSA). This can be considered as Overvalued.


What is the profitability of PFSA stock?

PROFUSA INC (PFSA) has a profitability rating of 0 / 10.


Can you provide the financial health for PFSA stock?

The financial health rating of PROFUSA INC (PFSA) is 0 / 10.